Physician profile
Emil Cohen
NPI 1952303356
$114,817.43
in general payments reported to CMS, 2019-2025
23 companies · $53K in 2025
The $53K reported for 2025 was more than what 97% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $5,026 · 2020: $250 · 2021: $7,566 · 2022: $11K · 2023: $8,551 · 2024: $29K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Consulting Fee: $5,410 · Food and Beverage: $2,206 · Travel and Lodging: $1,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,800.00 |
| Consulting Fee | $5,410.00 |
| Food and Beverage | $2,205.85 |
| Travel and Lodging | $1,266.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $98,498.43 | 2019-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Endologix LLC | $6,960.00 | 2022-2025 | Torus Stent Graft System, Endocross Device |
| Bard Peripheral Vascular, INC. | $4,016.24 | 2019-2022 | |
| Embolx, INC. | $1,850.00 | 2023 | |
| Becton, Dickinson and Company | $534.29 | 2019 | |
| Medtronic, INC. | $522.71 | 2021-2025 | Concertotm, Abre, Mvp |
| Inari Medical, INC. | $497.30 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $423.86 | 2022-2025 | General - Vascular Intervention, Therasphere Administration Set, Embold Fibered |
| Trisalus Life Sciences, INC. | $346.30 | 2022-2025 | Trinav Infusion System |
| Penumbra, INC. | $318.02 | 2024-2025 | Indigo System, Penumbra System |
| Terumo Medical Corporation | $204.93 | 2023-2025 | Azur Cx Detachable, Navicross, Angio-Seal |
| Angiodynamics, INC. | $144.07 | 2019 | |
| Balt USA, LLC | $134.27 | 2024 | Prestige Coil System |
| Davol INC. | $92.89 | 2019 | |
| W. L. Gore & Associates, INC. | $62.96 | 2020-2025 | Gore Viatorr Tips Endoprosthesis, Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $51.50 | 2019-2020 | |
| Cook Medical LLC | $39.22 | 2019-2024 | Icast Covered Stent System, 6mmx22mmx120cm |
| Stryker Corporation | $35.44 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Abbott Laboratories | $33.80 | 2023 | Perclose Prostyle |
| Shockwave Medical, INC | $18.04 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $17.59 | 2025 | Na |
| Instylla, INC. | $15.57 | 2024 | Instylla Microcatheter, Instylla Delivery Kit |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,750.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emil Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.